Eric Schwartz - Globus Medical Senior Vice President General Counsel

GMED -- USA Stock  

USD 51.84  0.49  0.95%

  President
Mr. Eric I. Schwartz is no longer Senior Vice President, General Counsel of the Company effective November 2, 2018. Prior to joining Globus Medical, Mr. Schwartz was a Member in the corporate practice of Cozen OConnor, a law firm based in Philadelphia. Before joining Cozen OConnor, Mr. Schwartz spent two years as Chief Operating Officer of CardioVIP, Inc., a venturebacked health care services company based in Sugar Land, Texas. He previously served as Executive Vice President and Chief Legal Officer of ERT, Inc., a Philadelphiabased provider of medical devices and research services to the biopharmaceutical industry. Prior to ERT, Mr. Schwartz spent 5 years at Johnson Johnson, serving as Assistant General Counsel and supporting several highgrowth businesses within the companys medical devices division, including Animas Corporationrationration and Ethicon Biosurgery. He had been Vice President and General Counsel of Animas prior to its acquisition by Johnson Johnson in 2006. Eric began his legal career as an associate at the law firms Skadden, Arps, Slate, Meagher Flom LLP in New York and Dechert LLP in Philadelphia
Age: 48    MBA    
610-930-1800  http://www.globusmedical.com
Schwartz received his B.A. and J.D. from the University of Virginia and holds an MBA in Finance with honors from the Wharton School of Business at the University of Pennsylvania.

Eric Schwartz Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 8.16 % which means that it generated profit of $8.16 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 12.02 % meaning that it created $12.02 on every $100 dollars invested by stockholders.
The company currently holds 1.98M in liabilities with Debt to Equity (D/E) ratio of 0.1 which may suggest the company is not taking enough advantage from borrowing. Globus Medical has Current Ratio of 6.8 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Thomas GephartDynatronics Corporation
2016
Stephen OklandSecond Sight Medical Products
2018
Scott UllemEdwards Lifesciences Corporatio
2014
Brad GreathouseENCISION INC
2014
Anthony MosesSecond Sight Medical Products
2015
Huimin WangEdwards Lifesciences Corporatio
2010
Robert CardonDynatronics Corporation
2007
Donald BoboEdwards Lifesciences Corporatio
2015
Catherine SzymanEdwards Lifesciences Corporatio
2015
David JacquesSecond Sight Medical Products
2017
Steven OklandSecond Sight Medical Products
2016
Peter GearyENCISION INC
2017
Douglas SampsonDynatronics Corporation
2009
James OgilvieDynatronics Corporation
2016
Bernard ZovighianEdwards Lifesciences Corporatio
2016
Alberto QuesadaEstablishment Labs Holdings
2017
Martin ShirleyDigirad Corporation
2016
Brian BakerDynatronics Corporation
2019
Larry WoodEdwards Lifesciences Corporatio
2018
David EricksonEdwards Lifesciences Corporatio
N/A
JeanLuc LemercierEdwards Lifesciences Corporatio
2017

Entity Summary

Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. Globus Medical, Inc. was founded in 2003 and is headquartered in Audubon, Pennsylvania. Globus Medical operates under Medical Devices classification in USA and is traded on BATS Exchange. It employs 1800 people.Globus Medical (GMED) is traded on BATS Exchange in USA. It is located in 2560 General Armistead Avenue and employs 1,800 people. Globus Medical is listed under Medical Equipment category by Fama And French industry classification.

Globus Medical Leadership Team

Steve Zarrilli, Director
David Paul, Co-Founder, Chairman, CEO, Chairman of Compensation Committee and Chairman of Nominating and Corporate Governance Committee
Eric Schwartz, Senior Vice President General Counsel
Ann Rhoads, Independent Director
Andrew Murphy, Group President Commercial Operations
Anthony Williams, Senior Vice President General Counsel
Robert Liptak, Independent Director
James Tobin, Director
Kurt Wheeler, Independent Director
Brett Murphy, Group President of Commercial Operations
Daniel Lemaitre, Independent Director
David Demski, Group President of Emerging Technologies, Director and Member of Nominating and Corporate Governance Committee
Daniel Scavilla, CFO and Sr. VP
David Davidar, Co-Founder, Sr. VP of Operations and Director

Stock Performance Indicators

Current Sentiment - GMED

Globus Medical Investor Sentiment

Most of Macroaxis users are currently bullish on Globus Medical. What is your judgment towards investing in Globus Medical? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please also check Risk vs Return Analysis. Please also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Search macroaxis.com